CXCL12 and ovarian carcinoma: For inhibition of the recruitment of TAMs, the CCL2/CCR2 axis barricade which is has been found to be helpful in a mouse ovarian cancer model (34), and disrupting the CXCL12/CXCR4 axis which prolongs the survival of a tumor mouse model (35) seem to be an encouraging therapy.